Celltech

Celltech Group
Public
Industry Biotechnology
Fate Acquired
Successor UCB
Founded 1980
Defunct 2004
Headquarters Slough, UK
Key people
 Goran Ando (CEO)

Celltech Group plc was a leading British-based biotechnology business based in Slough. It was listed on the London Stock Exchange and was a constituent of the FTSE 100 Index.

History

The Company was founded by Gerard Fairtlough in 1980 with finance from the National Enterprise Board.[1]

In 1999 the Company led consolidation in the UK biosciences market merging with Chiroscience plc and then buying Medeva plc.[2] Then in 2000 it bought Cistron, a US biosciences business.[3] It expanded into Germany in 2001 buying Thiemann, a German biosciences business,[4] and went on to buy Oxford Glycosciences in July 2003 for £102m.[5] Celltech was acquired by UCB, a Belgian drugmaker, in 2004.[6] Since then it has been known as UCB Celltech.

Operations

The Company was engaged in research and development of therapies for patients with serious diseases. Products included:[7]

See also

References

  1. ↑ Pharmatelevision
  2. ↑ UK Biotech Industry Consolidates As Celltech Buys Medeva for $915m
  3. ↑ UK's Celltech Buys Cistron of the US
  4. ↑ Celltech acquires German sales and marketing firm Thiemann for $44.6 mill
  5. ↑ ISIS
  6. ↑ Belgian drugmaker seeks to buy Celltec
  7. ↑ Businessweek: Celltech Group
This article is issued from Wikipedia - version of the 11/17/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.